T1	Intervention 10 46	ranolazine on A1C and glucose levels
T2	Intervention 198 281	concurrent antidiabetic therapy, and change in A1C and fasting plasma glucose (FPG)
T3	Intervention 318 424	standard treatment for diabetes and randomized to ranolazine or placebo within the MERLIN-TIMI-36 (MERLIN)
T4	Intervention 432 442	Ranolazine
T5	Intervention 567 620	glycemic and antidiabetes drug usage data from MERLIN
T6	Intervention 806 816	ranolazine
T7	Intervention 862 878	placebo-adjusted
T8	Intervention 908 918	ranolazine
T9	Intervention 1021 1031	ranolazine
T10	Intervention 1056 1063	placebo
T11	Intervention 1259 1269	ranolazine
T12	Intervention 1275 1282	placebo
T13	Intervention 1360 1370	ranolazine
T14	Intervention 1417 1427	Ranolazine
T15	Intervention 1443 1450	placebo
T16	Intervention 1544 1576	concurrent antidiabetic therapy,
T17	Intervention 1626 1685	Ranolazine, when added to concurrent antidiabetes treatment
